Efficacy of BIO K+ CL1285® in the reduction of antibiotic-associated diarrhea - A placebo controlled double-blind randomized, multi-center study

Archives of Medical Science

Volumn 6, Issue 1, 2010, Pages 56-64

  Dylewski, Joe ^a   Psaradellis, Eliofotisti ^b   Sampalis, John ^b,c  

^a ST MARY S HOSPITAL   (Canada)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Acidophilus; Antibiotic associated diarrhea; Lactobacillus; Probiotics

Indexed keywords

BIO K+ CL1285; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DYSPHAGIA; FECES INCONTINENCE; FEMALE; FLATULENCE; GASTRITIS; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING;

EID: 77949370649     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.13508     Document Type: Article

References (26)

1. Högenauer C, Hammer HF, Krejs GJ, Reisinger EC. Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 1998; 27: 702-10.
2. Young VB, Schmidt TM. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 2004; 42: 1203-6.
3. Wiström J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001; 47: 43-50.
4. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 1998; 16: 292-307.
5. Kaltenbach G, Heitz D. Antibiotic-associated diarrhea in the elderly [French]. Rev Med Interne 2004; 25: 46-53.
6. Beaugerie L, Petit JC. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol 2004; 18: 337-52.
7. Report of a joint FAO/WHO Working Group. Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada: FAO/WHO; ftp://ftp.fao.org/es/esn/ food/wgreport2.pdf. 2002. Ref Type: Data File.
8. Pedone CA, Bernabeau AO, Postaire ER. The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhea in children attending day care centers. Int J Clin Pract 1999; 53: 179-84.
9. Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007; 335: 80.
10. Wenus C, Goll R, Loken EB, Biong AS, Halvorsen DS, Florholmen J. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Eur J Clin Nutr 2008; 62: 299-301.
11. Beausoleil M, Fortier N, Guenette S, et al. Effect of a fermented milk combining lactobacillus acidophilus Cl1285 and lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol 2007; 21: 732-6.
12. Jones JL, Foxx-Orenstien AE. The role of probiotics in inflammatory bowel disease. Dig Dis Sci 2007; 52: 607-11.
13. Gionchetti P, Rizzello F, Campieri M. Probiotics in gastroenterology. Curr Opin Gasteroenterology 2002; 18: 235-9.
14. Boirivant M, Strober W. The mechanism of action of probiotics. Curr Opin Gasteroenterology 2007; 23: 679-92.
15. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101: 812-22.
16. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999; 135: 564-8.
17. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002; 324: 1361.
18. Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002; 16: 1461-7.
19. McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 1995; 90: 439-48.
20. Wunderlich PF, Braun L, Fumagalli I, et al. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 1989; 17: 333-8.
21. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Bellle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96: 981-8.
22. Rahimi R, Nikfar S, Rahimi F, et al. A meta-analysis of the benefit of probiotics in maintaining remission of human ulcerative colitis: evidence for prevention of disease relapse and maintenance of remission. Dig Dis Sci 2008; 53: 2524-31.
23. Nikfar S, Rahimi R, Rahimi F, Abdollahi M. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum 2008; 51: 1775-80.
24. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. A meta-analysis of the benefit of probiotics in maintaining remission of human ulcerative colitis: evidence for prevention of disease relapse and maintenance of remission. Arch Med Sci 2008; 4: 185-90.
25. Elahi B, Nikfar S, Derakshani S, Vafaie M, Abdollahi M. On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. Dig Dis Sci 2007; 53: 1278-84.
26. Kelly CP, Pothoulakis C, Lamont JT. Clostridium difficile colitis. N Engl J Med 1994; 330: 257-62.